Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine vs Levocetirizine in Chronic Idiopathic Urticaria
NCT00346606Phase 4Unknown
- Sponsor
- Lotus Pharmaceutical
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of desloratadine in chronic idiopathic urticaria (CIU), sponsored by Lotus Pharmaceutical. Status: unknown.
02
Drugs
desloratadine
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on NCT00346606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00346606.